Diving into Part II of the CRISPR Workflow series, we are exploring how our panel believes feel that current tools, techniques and methods will be impacted due to the emergence of CRISPR technology in their labs. We know that while many of our clients are seeking preeminence in newly formed product lines for CRISPR/Cas9 kits and consumables, the […]
Following the insights gained from our The Market for CRISPR/Cas9 Genome Editing Products report (released June 2015 on the Interactive Market Intelligence platform), we fielded a follow-up questionnaire to our expert panel to quantify how the emergence of CRISPR is impacting the use of traditional tools and techniques. The following insights are Part One of a series […]
BioInformatics has announced three significant upgrades to the Interactive Market Intelligence experience. In addition to much better on-site performance and faster page loading speeds, we have added Net Promoter Score and a Content section, which contains a summarized export and full questionnaire of the report. IMI, launched this year, has transformed the way life science market data […]
We’re officially into the second half of 2015 and, inevitably, smack dab in the “Summer Doldrums.” While a good portion of the world takes their holiday at this time of year, BioInformatics is in the midst of preparing its most comprehensive report, The 2016 Global Life Science Funding and Budget Outlook. Comprised of both secondary […]
